TSXV:RHT.H - Post by User
Post by
TicTacToon Nov 02, 2020 3:34am
152 Views
Post# 31821451
Device sales is not indicative of SaaS business expansion
Device sales is not indicative of SaaS business expansion They just sold them on market to desesperatly generate cash, at present this company is still the failure to succeed in telehealth. Many competitors skyrocket during Covid (Livango, Cloud MD, Well Healthcare) and their shares follows.
RHT is still a mess, now let's see if they reach a turning point but we all know CEO is not reliable.
Maybe they will succeed to ramp up SaaS business (as due in 2017, then 18, then 19, then 20) but still highly risky.
2021 could be turning point but it is last opportunity, will see end november guidance. https://themoneynarrative.wordpress.com/2019/12/02/reliq-health-technologies-rht-v-shareholder-update-webinar-dec-2019/#more-1613 - Assets (monitoring devices inventory) on hand with a market value of over $3 million, which could be sold independently of the subscription model if additional capital required (at a fair market value, as they are in high demand, and not at a liquidation price, generating a profit for the company);